Table 1. Association of CPEB3 expression with clinicopathological characteristics in 99 patients with CRC.
Variable | n | CPEB3 | P | |
Low (n = 53) | High (n = 46) | |||
Age (years) | ||||
< 70 (45-69) | 54 | 32 | 22 | 0.147 |
≥ 70 (70-91) | 45 | 21 | 24 | |
Gender | ||||
Male | 58 | 30 | 28 | 0.411 |
Female | 41 | 23 | 18 | |
Pathological grade | ||||
Well | 69 | 35 | 34 | 0.265 |
Moderate- Poor | 30 | 18 | 12 | |
pT status | ||||
T1-2 | 4 | 1 | 3 | 0.257 |
T3-4 | 95 | 52 | 43 | |
pN status | ||||
N0 | 52 | 23 | 29 | 0.040 |
N1 | 47 | 30 | 17 | |
pM status | ||||
M0 | 94 | 48 | 46 | 0.040 |
M1 | 5 | 5 | 0 | |
Tumor stage | ||||
I/II | 51 | 22 | 29 | 0.026 |
III/IV | 48 | 31 | 17 | |
Tumor size | ||||
≤ 5 cm | 56 | 32 | 24 | 0.268 |
> 5 cm | 43 | 21 | 22 | |
Tumor number | ||||
Single | 95 | 49 | 46 | 0.078 |
Multiple | 4 | 4 | 0 |